A restriction endonuclease that recognizes the sequence AT^CG_AT.
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0444872
- Awardee
- New England Biolabs Inc
- Contracting organization
- University of Virginia
- Cumulative value
- $80.00
About this award
The University of Virginia awarded contract A207_PO-0444872 to New England Biolabs Inc on June 3, 2026, for the delivery of a restriction endonuclease enzyme. The contract specifies a single unit of a restriction endonuclease that recognizes the AT^CG_AT sequence, with delivery directed to Leigh Ann Bradley. The total contract value is $80.
This procurement represents a one-time purchase of laboratory research materials to support the University of Virginia's scientific operations. The contract contains a single line item valued at $80 per unit, reflecting a specialized molecular biology reagent typical of academic research requirements. No specific performance period extending beyond the award date of June 3, 2026, is indicated in the contract documentation.
Line items
| Item | Total |
|---|---|
| A restriction endonuclease that recognizes the sequence AT^CG_AT. | $80.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0444872?
Contract A207_PO-0444872 was awarded to New England Biolabs Inc by University of Virginia on June 3, 2026.
How much is contract A207_PO-0444872 worth?
Its cumulative value is $80.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award